TNF-α and endotoxin serum levels in cancer patients undergoing intraperitoneal hyperthermic perfusion

International Journal of Hyperthermia

Volumn 12, Issue 5, 1996, Pages 607-615

  Sumida, M ^a   Isawa, E ^a   Kobayashi, K ^a   Inaba, H ^b   Fujimoto, S ^a  

^a Social Ins Funabashi Ctrl Hospital   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endotoxin; Intraperitoneal hyperthermic perfusion; TNF

Indexed keywords

ENDOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASSAY; BLOOD LEVEL; BLOOD SAMPLING; CELL LYSATE; CLINICAL ARTICLE; DIGESTIVE SYSTEM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INFLAMMATION; MALE; PERITONEUM; PULMONARY ARTERY; VENOUS BLOOD;

EID: 0029861322     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609027669     Document Type: Article

References (30)

1. BARLOGIE, B., CORRY, P. M., and DREWINKO, B., 1980, In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum (II) and mitomycin C. Cancer Research, 40, 1165-1168.
2. BEUTLER, B. A., MILSARK, I. W., and CERAMI, A., 1985, Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. Journal of Immunology, 135, 3972-3977.
3. CAMUSSI, G., BUSSOLINI, F., SALVIDIO, G., and BAGLIONI, C., 1987, Tumor necrosis factor/ cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. Journal of Experimental Medicine, 166, 1390-1404.
4. CANNON, J. G., TOMPKINS, R. G., and GELFAND, J. A., 1990, Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. Journal of Infectious Disease, 161, 79-84.
5. CHAPMAN, P. B., LESTER, T. J., and CASPER, E. S., 1987, Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. Journal of Clinical Oncology, 5, 1942-1951.
6. CREAVEN, P. J., PLAGER, J. E., and DUPERE, S., 1987, Phase 1 clinical trial of recombinant human tumor necrosis factor. Cancer Chemotherapy and Pharmacology, 20, 137-144.
7. DAMAS, P., REUTER, A., GYSEN, P., DEMONTY, J., LAMY, M., and FRANCHIMONT, P., 1989, Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Critical Care Medicine, 17, 975-978.
8. DINARELLO, C. A., and NETA, R., 1990, An overview on interleukin-1 as a therapeutic agent. Biotherapy, 1, 245-254.
9. DUBOIS, M. F., FERRIEUX, C., and LEBON, P., 1989, Synergistic cytotoxic effects of recombinant human tumor necrosis factor, interferons, and heat stress. Cancer Research, 49, 5618-5622.
10. FONG, Y., MOLDAWER, L. L., SHIRES, G. T., and LOWRY, S. F., 1990, The biological characteristics of cytokines and their implication in surgical injury. Surgery, Gynecology and Obstetrics, 170, 363-378.
11. FUJIMOTO, S., SHRESTHA, R. D., KOKUBUN, M., KOBAYASHI, K., KIUCHI, S., TAKAHASHI, M., KONKO, C., OHTA, M., KOIKE, S., KITSUKAWA, Y., MIZUTANI, M., and OKUI, K., 1989, Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer, 64, 154-161.
12. GATHIRAM, P., GAFFIN, S. L., BROCK-UTNE, J. G., and WELLS, M. T., 1987, Time course of endotoxemia and cardiovascular changes in heat-stressed primates. Aviation, Space, and Environmental Medicine, 58, 1071-1074.
13. GRABER, C. D., REINHOLD, R. B., BREMAN, J. G., HARLEY, R. A., and HENNIGAR, G. R., 1971, Fatal heat stroke. JAMA, 216, 1195-1196.
14. HART, P. H., VITTI, G. F., BURGESS, D. R., WHITT, G. A., PICCOLI, D. S., and HAMILTON, J. A., 1989, Potential antiinflammatory effects of IL-4: suppression of human monocyte TNF α, IL-1 and PGE2. Proceeding of the National Academy of Sciences of USA, 86, 3803-3807.
15. JÄÄTTELÄ, M., and WISSING, D., 1993, Heat-shock proteins protect cells from monocyte cytotoxicity: Possible mechanism of self-protection. Journal of Experimental Medicine, 177, 231-236.
16. MADERAZO, E. G., BREAUX, S. P., and WONICK, C. L., 1986, Protective effects of ibuprofen and methylprednisolone on chemotactic factor-induced transcutaneus hypoxia. Journal of Pharmacology and Experimental Therapeutics, 238, 453.
17. MARSHALL, J., and SWEENEY, D., 1990, Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. Archives of Surgery, 125, 17-23.
18. MATHISON, J. C., WOLFSON, E., and ULEVITCH, R. J., 1988, Participation of tumor necrosis factor in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. Journal of Clinical Investigation, 81, 1925-1937.
19. MICHIE, H. R., MANOGUE, K. R., SPRIGGS, D. R., REVHAUG, A., O'DWYER, S., DINARELLO, C. A., CERAMI, A., WOLFF, S. M., and WILMORE, D. W., 1988, Detection of circulating tumor necrosis factor after endotoxin administration. New England Journal of Medicine, 318, 1481-1486.
20. MICHIE, H. R., and WILMORE, D. W., 1990, Sepsis and tumor necrosis factor-Bedfellows that cannot be ignored. Annals of Surgery, 212, 653-654.
21. SHAPIRO, L., and GELFAND, J. A., 1993, Cytokines and sepsis: pathophysiology and therapy. New Horizons, 1, 13-22.
22. SHIGLETON, W. W., PARKER, R. T., and MAHALEY, S., 1961, Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery, 50, 260-265.
23. SPRATT, J. S., ADCOCK, R. A., MUSKOVIN, M., SHERRILL, R., and MCKEOWN, J., 1980, Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Research, 40, 256-260.
24. SPRINGGS, D. R., HERMAN, M. L., and MICHIE, H., 1988, Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. Journal of the National Cancer Institute, 80, 1039-1044.
25. SONE, S., YANAGAWA, H., NISHIOKA, Y., ORINO, E., BHASKARAN, G., NII, A., MIZUNO, K., HEIKE, Y., OGUSHI, F., and OGURA, T., 1992, Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumor necrosis factor-α and interleukin-1. European Respiratory Journal, 5, 174-181.
26. TRACEY, K. J., BEUTLER, B., LOWRY, S. F., MERRYWEATHER, J., WOLPE, S., MILSARK, I. W., HARIRI, R. J., ZENTELLA, A., ALBERT, J. D., SHIRES, G. T., and CERAMI, A., 1986, Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470-474.
27. TRACEY, K. J., FONG, Y., HESSE, D. G., MANOGUE, K. R., LEE, A. T., KUO, G. C., LOWRY, S. F., and CERAMI, A., 1987, Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, 330, 662-664.
28. VALONE, F. H., and EPSTEIN, L. B., 1988, Diphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. Journal of Immunology, 141, 3945-3950.
29. VENEZIO, F. R., DI VINCENZO, C., PEARLMAN, F., and PHAIR, J. P., 1985, Effects of the new nonsteroidal anti-inflammatory agents, ibuprofen, fenoprofen, and sulindac, on neutrophil adherence. Journal of Infectious Disease, 152, 690-694.
30. WAGGE, A., 1987, Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clinical Immunology and Immunopathology, 45, 348-355.